April 25, 2018
A new tool has been created to measure patient uncertainty to predict which patients might return to the emergency department (ED) after discharge.
April 25, 2018
Takeda Pharmaceutical has increased its bid to purchase Shire Plc to $64 billion; a process for reviewing drug patents has been ruled constitutional by the Supreme Court of the United States; at the University of California, Los Angeles, an “unspoken taboo” against reusing transplanted kidneys is being challenged.
April 24, 2018
A panel of experts in infectious disease and managed care to discuss management of HIV, including the need for individualized care and the role for newer treatments options.
April 23, 2018
HHS will shift federal funding aimed at reducing teen pregnancy rates to focus on programs that teach abstinence; relying on data about doctor-diagnosed arthritis alone may miss almost half of cases in middle aged adults; the Trump administration is seeking to reverse an Obama administration decision preventing healthcare discriminating against transgender patients.
April 21, 2018
With chimeric antigen receptor (CAR) T-cell therapy being so new, there is going to be a learning curve as providers become more educated about the treatments, the manufacturing process, and the toxicities, Houston Holmes, MD, MBA, FACP, a medical oncologist with Texas Oncology, explained at the Community Oncology Alliance’s (COA) 2018 Community Oncology Conference.
April 19, 2018
Having numerous therapies to treat prostate cancer can actually be a bad thing—it makes it difficult to design clinical trials for new therapies coming into the space, explained Joe O'Sullivan, MD, FRCR, clinical professor, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast.
April 19, 2018
A novel drug that targets MDMX and MDM2, which inhibit a protein that suppresses tumors when they are overexpressed, has tripled the median survival rate in an animal model of human acute myeloid leukemia, according to new research.
April 16, 2018
Risk has very different meanings depending on whether one views it from a clinical or financial perspective.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!